Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV and Oral Amiodarone vs Oral Amiodarone Post-Ablation for Persistent AF
NCT06742866Not yet recruiting
- Sponsor
- Shanghai Chest Hospital
- Start
- Dec 2024
- Primary completion
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of amiodarone in Atrial fibrillation (AFib) (2 arms), sponsored by Shanghai Chest Hospital. Primary endpoint: Recurrence of atrial arrhythmia lasting more than 30 seconds at 12 months. Planned start Dec 2024; status: not yet recruiting.
02
Drugs
amiodarone
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT06742866.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06742866.